NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025 ...Middle East

ZURICH, Oct. 23, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP) (Nasdaq: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system ("CNS") disorders, and Kadimastem Ltd. (TASE: KDST) ("Kadimastem"), an advanced...

Hence then, the article about nls and kadimastem announce receipt of nasdaq approval merger expected to close on october 30 2025 was published today ( Thursday 23/10/2025 - 01:06 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025 )

Also on site :

• Hundreds of flights delayed at O'Hare after pipe burst at air traffic control tower
• ‘High School Musical’ Turns 20 Today! See Where the Cast Is Now
• Two dead in floods & torrential rains sweeping through Tunisia